InvestSMART

Neurotech International Limited (ASX: NTI) - Announcements

- Current share price for NTI : $0.014

ASX company news and announcements for Neurotech International Limited (NTI) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Neurotech International Limited (NTI) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Neurotech International Limited (NTI), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Neurotech International Limited (NTI)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$19 Results of General Meeting 12 Mar 2026 2:10PM $0.012 $0.014 risen by 21.74%
$19 Appendix 4D & Half Year Report 26 Feb 2026 6:15PM $0.014 $0.014 fallen by 0%
$19 Positive 90-day GLP toxicology study results in non-rodents 23 Feb 2026 9:45AM $0.014 $0.014 fallen by 0%
$19 NTI Collaborates with University of Sydney in Rett program 18 Feb 2026 9:38AM $0.014 $0.014 fallen by 0%
$19 Notice of General Meeting/Proxy Form 10 Feb 2026 4:10PM $0.014 $0.014 fallen by 0%
$19 Approval received for NTI164 Phase 3 Clinical Study in ASD 2 Feb 2026 9:36AM $0.013 $0.014 risen by 7.69%
$19 Quarterly Activities/Appendix 4C Cash Flow Report 30 Jan 2026 8:56AM $0.015 $0.014 fallen by 6.67%
$19 PANS Data Published in Leading Scientific Journal 15 Jan 2026 9:35AM $0.014 $0.014 fallen by 0%
$19 Secondary Trading Notice 24 Dec 2025 1:32PM $0.016 $0.014 fallen by 9.68%
$19 Application for quotation of securities - NTI 24 Dec 2025 1:31PM $0.016 $0.014 fallen by 9.68%
$19 Change of Director's Interest Notice 23 Dec 2025 12:03PM $0.015 $0.014 fallen by 6.67%
$19 Notification of cessation of securities - NTI 23 Dec 2025 12:01PM $0.015 $0.014 fallen by 6.67%
$19 Proposed issue of securities - NTI 17 Dec 2025 10:02AM $0.019 $0.014 fallen by 24.32%
$19 Proposed issue of securities - NTI 17 Dec 2025 10:02AM $0.019 $0.014 fallen by 24.32%
$19 Binding Commitments Received for a $4 Million Placement 17 Dec 2025 10:02AM $0.019 $0.014 fallen by 24.32%
$19 Trading Halt 15 Dec 2025 9:15AM $0.019 $0.014 fallen by 24.32%
$19 Results of Meeting 20 Nov 2025 12:25PM $0.018 $0.014 fallen by 22.22%
$19 Presentation to 2025 Annual General Meeting 20 Nov 2025 9:20AM $0.018 $0.014 fallen by 22.22%
$19 Neurotech receives $4.73m R&D Tax Incentive Refund 12 Nov 2025 9:53AM $0.017 $0.014 fallen by 17.65%
$19 Quarterly Activities/Appendix 4C Cash Flow Report 28 Oct 2025 11:13AM $0.017 $0.014 fallen by 17.65%
$19 Notice of Annual General Meeting/Proxy Form 20 Oct 2025 3:21PM $0.016 $0.014 fallen by 12.50%
$19 Annual Report (Typeset) 16 Oct 2025 1:14PM $0.018 $0.014 fallen by 22.22%
$19 US FDA Rare Pediatric Disease Designation in Rett syndrome 8 Oct 2025 9:24AM $0.019 $0.014 fallen by 26.32%
$19 Neurotech initiates NTI164 Authorised Prescriber Program 23 Sep 2025 9:17AM $0.016 $0.014 fallen by 12.50%
$19 Release of Shares from Voluntary Escrow 5 Sep 2025 4:32PM $0.014 $0.014 fallen by 0%

26 - 50 of 683 results

Page 2 of 28

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.